Tirzepatide vs. Semaglutide: What a New 2026 Study Found for Weight Loss

If you’re deciding between the two big names in GLP-1 weight loss — tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) — a large new study published in June 2026 just gave the clearest real-world look yet at how they compare. Here’s what it found, and just as importantly, what it doesn’t mean for your decision.

What the study found

Researchers analyzed de-identified health records from more than 20,000 patients — about 10,000 on each medication, carefully matched so the groups were comparable. Across up to two years of real-world use, tirzepatide came out ahead on weight loss:

14.7%
average weight loss on tirzepatide
10.8%
average weight loss on semaglutide
Real-world analysis of ~10,300 matched patients per group, published June 2026 (PNAS Nexus).

The gap showed up in a few ways. People on tirzepatide were nearly twice as likely to be “high responders” — losing more than 15% of their body weight in the first year (about 43% vs 22%). And somewhat surprisingly, the tirzepatide group reported fewer common side effects like nausea, vomiting, and fatigue, not more.

This isn’t an outlier finding. It lines up with the head-to-head SURMOUNT-5 clinical trial and earlier real-world data, all pointing the same direction.

What it means — and what it doesn’t

It’s tempting to read “tirzepatide wins” and assume it’s simply the better choice for everyone. That’s not what the data says. A couple of important caveats:

  • These are averages, and individual results vary enormously. In the same study, real-world outcomes ranged from minimal weight loss to more than 25% of body weight. The “better” drug on a chart isn’t automatically the better drug for you.
  • Weight loss isn’t the only factor. Tolerability, cost and insurance coverage, availability, other health conditions, and how your body responds all matter — and any of them can make semaglutide the right call for a given person.

Bottom line: this study is a strong data point in tirzepatide’s favor for raw weight loss, but choosing a GLP-1 is still an individual medical decision — not something to settle from a headline.

It’s not just the number on the scale

Here’s the part most weight-loss headlines skip: how much of what you lose is fat versus muscle. Rapid weight loss of any kind can take lean muscle along with fat, and muscle is what keeps your metabolism strong and the weight off long-term. That’s why we track body composition with InBody scans rather than just watching the scale — and why protein intake and resistance training are part of every program here, not an afterthought.

One more thing worth knowing if you’re losing weight quickly: it can change your face, not just your body. We wrote separately about “Ozempic face” and how it’s treated.

How we choose between them at Defiance

We offer both tirzepatide and semaglutide, and the right starting point depends on you — your health history, your labs, your goals, your insurance reality, and how you tolerate the medication. Treatment is physician-supervised, built on real bloodwork, and adjusted as we track your progress. Our Centennial clinic serves the south Denver metro and the Denver Tech Center, and our Alamosa clinic serves the San Luis Valley.

Common questions

Is tirzepatide better than semaglutide?

On average, current evidence shows greater weight loss with tirzepatide. But “on average” isn’t “for everyone” — the best choice depends on your health, tolerance, coverage, and goals, which is what a consultation sorts out.

Is Mounjaro the same as tirzepatide, and Ozempic the same as semaglutide?

Yes. Mounjaro and Zepbound are brand names for tirzepatide; Ozempic and Wegovy are brand names for semaglutide. The studies compare the underlying medications.

Should I switch medications based on this study?

Not on your own. If your current program is working and well-tolerated, that matters. If it isn’t, this is worth discussing with your provider — switching is a clinical decision, not a default.

Does Defiance Health offer both?

Yes. We prescribe both tirzepatide and semaglutide as part of a physician-supervised medical weight loss program in Centennial and Alamosa, with body composition tracking and lab work included.

Not sure which program fits you?

Book a consultation in Centennial or Alamosa. We’ll look at your labs and goals and build a plan around the right medication for you — not a one-size headline.

Explore Medical Weight Loss

This article summarizes published research for education and isn’t medical advice or a recommendation to start, stop, or switch any medication. Treatment decisions are made with your provider after evaluation. — Jessica Lara, PA-C, Defiance Health

Next
Next

What Is "Ozempic Face"? Why GLP-1 Weight Loss Changes Your Face